554 related articles for article (PubMed ID: 28967863)
21. Dissecting the role of SWI/SNF component ARID1B in steady-state hematopoiesis.
Madan V; Shyamsunder P; Dakle P; Woon TW; Han L; Cao Z; Nordin HBM; Jizhong S; Shuizhou Y; Hossain MZ; Koeffler HP
Blood Adv; 2023 Nov; 7(21):6553-6566. PubMed ID: 37611161
[TBL] [Abstract][Full Text] [Related]
22. Co-regulation of transcription by BRG1 and BRM, two mutually exclusive SWI/SNF ATPase subunits.
Raab JR; Runge JS; Spear CC; Magnuson T
Epigenetics Chromatin; 2017 Dec; 10(1):62. PubMed ID: 29273066
[TBL] [Abstract][Full Text] [Related]
23. Identification of a novel GR-ARID1a-P53BP1 protein complex involved in DNA damage repair and cell cycle regulation.
Stubbs FE; Flynn BP; Rivers CA; Birnie MT; Herman A; Swinstead EE; Baek S; Fang H; Temple J; Carroll JS; Hager GL; Lightman SL; Conway-Campbell BL
Oncogene; 2022 Dec; 41(50):5347-5360. PubMed ID: 36344675
[TBL] [Abstract][Full Text] [Related]
24. Concurrent ARID1A and ARID1B inactivation in endometrial and ovarian dedifferentiated carcinomas.
Coatham M; Li X; Karnezis AN; Hoang LN; Tessier-Cloutier B; Meng B; Soslow RA; Blake Gilks C; Huntsman DG; Stewart CJ; Postovit LM; Köbel M; Lee CH
Mod Pathol; 2016 Dec; 29(12):1586-1593. PubMed ID: 27562491
[TBL] [Abstract][Full Text] [Related]
25. [Tumor suppressor role of chromatin-remodeling factor ARID1A].
Guo XQ; Zhang QX; Huang WR; Duan XL; Cai ZM
Yi Chuan; 2013 Mar; 35(3):255-61. PubMed ID: 23575531
[TBL] [Abstract][Full Text] [Related]
26. ARID1A-mutated ovarian cancers depend on HDAC6 activity.
Bitler BG; Wu S; Park PH; Hai Y; Aird KM; Wang Y; Zhai Y; Kossenkov AV; Vara-Ailor A; Rauscher FJ; Zou W; Speicher DW; Huntsman DG; Conejo-Garcia JR; Cho KR; Christianson DW; Zhang R
Nat Cell Biol; 2017 Aug; 19(8):962-973. PubMed ID: 28737768
[TBL] [Abstract][Full Text] [Related]
27. The Role of the AT-Rich Interaction Domain 1A Gene (
Li JJ; Lee CS
Genes (Basel); 2023 Dec; 15(1):. PubMed ID: 38275587
[TBL] [Abstract][Full Text] [Related]
28. mRNA Display Identifies Potent, Paralog-Selective Peptidic Ligands for ARID1B.
Cremosnik GS; Mesrouze Y; Zueger P; Furkert D; Grandjean F; Argoti D; Mermet-Meillon F; Bauer MR; Brittain S; Rogemoser P; Yang W; Giovannoni J; McGregor L; Tang J; Knapp M; Holzinger S; Buhr S; Muller L; Leder L; Xie L; Fernandez C; Nieto-Oberhuber C; Chène P; Galli GG; Sesterhenn F
ACS Chem Biol; 2024 May; 19(5):1142-1150. PubMed ID: 38655884
[TBL] [Abstract][Full Text] [Related]
29. The Evolutionary Conserved SWI/SNF Subunits ARID1A and ARID1B Are Key Modulators of Pluripotency and Cell-Fate Determination.
Pagliaroli L; Trizzino M
Front Cell Dev Biol; 2021; 9():643361. PubMed ID: 33748136
[TBL] [Abstract][Full Text] [Related]
30. SWI/SNF Alterations in Squamous Bladder Cancers.
Achenbach F; Rose M; Ortiz-Brüchle N; Seillier L; Knüchel R; Weyerer V; Hartmann A; Morsch R; Maurer A; Ecke TH; Garczyk S; Gaisa NT
Genes (Basel); 2020 Nov; 11(11):. PubMed ID: 33227989
[TBL] [Abstract][Full Text] [Related]
31. Targeting ARID1A mutations in cancer.
Mullen J; Kato S; Sicklick JK; Kurzrock R
Cancer Treat Rev; 2021 Nov; 100():102287. PubMed ID: 34619527
[TBL] [Abstract][Full Text] [Related]
32. Inactivating mutations in SWI/SNF chromatin remodeling genes in human cancer.
Oike T; Ogiwara H; Nakano T; Yokota J; Kohno T
Jpn J Clin Oncol; 2013 Sep; 43(9):849-55. PubMed ID: 23904343
[TBL] [Abstract][Full Text] [Related]
33. Targeting AURKA-CDC25C axis to induce synthetic lethality in ARID1A-deficient colorectal cancer cells.
Wu C; Lyu J; Yang EJ; Liu Y; Zhang B; Shim JS
Nat Commun; 2018 Aug; 9(1):3212. PubMed ID: 30097580
[TBL] [Abstract][Full Text] [Related]
34. Functional selectivity of recombinant mammalian SWI/SNF subunits.
Kadam S; McAlpine GS; Phelan ML; Kingston RE; Jones KA; Emerson BM
Genes Dev; 2000 Oct; 14(19):2441-51. PubMed ID: 11018012
[TBL] [Abstract][Full Text] [Related]
35. Genome-Wide Analysis of the Nucleosome Landscape in Individuals with Coffin-Siris Syndrome.
Kalmbach A; Schröder C; Klein-Hitpass L; Nordström K; Ulz P; Heitzer E; Speicher MR; Rahmann S; Wieczorek D; Horsthemke B; Bramswig NC
Cytogenet Genome Res; 2019; 159(1):1-11. PubMed ID: 31658463
[TBL] [Abstract][Full Text] [Related]
36. Repurposing Pan-HDAC Inhibitors for ARID1A-Mutated Ovarian Cancer.
Fukumoto T; Park PH; Wu S; Fatkhutdinov N; Karakashev S; Nacarelli T; Kossenkov AV; Speicher DW; Jean S; Zhang L; Wang TL; Shih IM; Conejo-Garcia JR; Bitler BG; Zhang R
Cell Rep; 2018 Mar; 22(13):3393-3400. PubMed ID: 29590609
[TBL] [Abstract][Full Text] [Related]
37. Dysregulation of SWI/SNF Chromatin Remodelers in NSCLC: Its Influence on Cancer Therapies including Immunotherapy.
Shi Y; Shin DS
Biomolecules; 2023 Jun; 13(6):. PubMed ID: 37371564
[TBL] [Abstract][Full Text] [Related]
38. ARID1A facilitates KRAS signaling-regulated enhancer activity in an AP1-dependent manner in colorectal cancer cells.
Sen M; Wang X; Hamdan FH; Rapp J; Eggert J; Kosinsky RL; Wegwitz F; Kutschat AP; Younesi FS; Gaedcke J; Grade M; Hessmann E; Papantonis A; Strӧbel P; Johnsen SA
Clin Epigenetics; 2019 Jun; 11(1):92. PubMed ID: 31217031
[TBL] [Abstract][Full Text] [Related]
39. ARID1A-deficiency in urothelial bladder cancer: No predictive biomarker for EZH2-inhibitor treatment response?
Garczyk S; Schneider U; Lurje I; Becker K; Vögeli TA; Gaisa NT; Knüchel R
PLoS One; 2018; 13(8):e0202965. PubMed ID: 30138427
[TBL] [Abstract][Full Text] [Related]
40. ARID1A deficiency weakens BRG1-RAD21 interaction that jeopardizes chromatin compactness and drives liver cancer cell metastasis.
Shang XY; Shi Y; He DD; Wang L; Luo Q; Deng CH; Qu YL; Wang N; Han ZG
Cell Death Dis; 2021 Oct; 12(11):990. PubMed ID: 34689165
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
